Related Articles
Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma
MGMT promoter methylation in serum and cerebrospinal fluid as a tumor‑specific biomarker of glioma
Association between IDH1/2 mutations and brain glioma grade
Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma
Molecular characteristics of pediatric non-ependymal, non‑pilocytic gliomas associated with resistance to temozolomide